Cargando…
Tocilizumab como posible causa de colitis isquémica
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661921/ https://www.ncbi.nlm.nih.gov/pubmed/33190937 http://dx.doi.org/10.1016/j.gastrohep.2020.07.016 |
| _version_ | 1783609298198200320 |
|---|---|
| author | Forneiro Pérez, Rocío Dabán López, Pablo Zurita Saavedra, María Sol Hernández García, María Dolores Mirón Pozo, Benito |
| author_facet | Forneiro Pérez, Rocío Dabán López, Pablo Zurita Saavedra, María Sol Hernández García, María Dolores Mirón Pozo, Benito |
| author_sort | Forneiro Pérez, Rocío |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7661921 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76619212020-11-13 Tocilizumab como posible causa de colitis isquémica Forneiro Pérez, Rocío Dabán López, Pablo Zurita Saavedra, María Sol Hernández García, María Dolores Mirón Pozo, Benito Gastroenterol Hepatol Carta Científica Elsevier España, S.L.U. 2021-05 2020-11-13 /pmc/articles/PMC7661921/ /pubmed/33190937 http://dx.doi.org/10.1016/j.gastrohep.2020.07.016 Text en © 2020 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Carta Científica Forneiro Pérez, Rocío Dabán López, Pablo Zurita Saavedra, María Sol Hernández García, María Dolores Mirón Pozo, Benito Tocilizumab como posible causa de colitis isquémica |
| title | Tocilizumab como posible causa de colitis isquémica |
| title_full | Tocilizumab como posible causa de colitis isquémica |
| title_fullStr | Tocilizumab como posible causa de colitis isquémica |
| title_full_unstemmed | Tocilizumab como posible causa de colitis isquémica |
| title_short | Tocilizumab como posible causa de colitis isquémica |
| title_sort | tocilizumab como posible causa de colitis isquémica |
| topic | Carta Científica |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661921/ https://www.ncbi.nlm.nih.gov/pubmed/33190937 http://dx.doi.org/10.1016/j.gastrohep.2020.07.016 |
| work_keys_str_mv | AT forneiroperezrocio tocilizumabcomoposiblecausadecolitisisquemica AT dabanlopezpablo tocilizumabcomoposiblecausadecolitisisquemica AT zuritasaavedramariasol tocilizumabcomoposiblecausadecolitisisquemica AT hernandezgarciamariadolores tocilizumabcomoposiblecausadecolitisisquemica AT mironpozobenito tocilizumabcomoposiblecausadecolitisisquemica |